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To assess the relationship between iInlnune systeln 
and nevi, we studied two lnodels of ilnlnunodefi-
ciency caused by different lnechanislns, i.e., virus 
and drug. Our rationale was that if an excess of nevi 
was found in these two epidelniologic lnodels, it 
could be concluded that the excess was due to ilnlnu-
no deficiency itself rather than its cause. One hundred 
ten renal transplant recipients (RTR) were cOlnpared 
with age-, sex-, and phenotype-lnatched controls. 
Eighty four HIV -positive patients (HIV +) were COln-
pared with silnilarly lnatched controls. Nevi < 5 lnln 
(N < 5) or ~ 5 lnln (N ~ 5) were counted in three sites 
representative of regularly, interlnittently, and never 
sun-exposed sites. The nUlnber ofN < 5 was higher in 
RTR (p < 0.001) and in HIV + (p < 0.001) than in 
R ecent case control studies have shown that there is an excess of benign melanocytic nevi in long- term survivors of childhood cancer (Hughes el ai, 1989; . De Wit e/ ai, 1990; Green ef ai , 1993) and in children with renal allografts (Smith el ai, 1993). A 
possible explanation for these findings is that chemotherapeutic 
agents promote nevi, but it is also possible that the excess of nevi is 
due to immune depression. 
Immune surveillance is a well-demonstrated concept for skin 
cancers (Fisher and Kripke, 1982). It is also accepted for melanoma 
(Ross, 1989), and host immune response provides a basis for new 
cancer therapies (ltoh el al 1992). Recent studies in renal allografts 
recipients and in survivors from childhood cancers raise the ques-
tion of whether this concept also applies to nevus. Confirmation of 
a link between immune defect and number of nevi would have an 
important pathogenic implication with regard to the sun-induced 
development of n evi. Although the development of nevi is associ-
ated with sun exposure and fair complexion (Green and Swerdlow, 
1989), the m echanisms of the promotion of nevus by sun radiation 
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respective controls. N ~ 5 were significantly higher 
only in RTR. These differences tended to be the salne 
for all sites and persisted after adjustlnent for possi-
ble confounding factors. The incidence of atypical 
nevus was higher in RTR than in controls. 
Imlnunodeficiency seelnS to prolnote the occur-
rence of nevi. This supports the concept of ilnlnune 
surveillance of nevi and raises the question of 
whether sun-induced ilnlnune suppression plays a 
role in the developlnent of nevi. As nevi are risk 
lnarkers for Inelanolna, a higher incidence of lnela-
nOlna could be expected in ilnlnunocolnprolnised 
patients. Key Ivoyds: tlleiallom.a./pl·evelltiolt/Slllt exposll/'e. 
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are not elucidated. Ultraviolet-induced immune suppression (Krut-
mann and Elmets, 1988) could be one of these mechanisms. 
The influence of immune status on the development of melano-
cytic nevi is also important to predict the risk of ca.ncer in 
iml11unocompromised patients because the number of nevi is the 
best risk £ilctor for melanoma (Grob e/ ai, 1990). With the 
increasing number ,llld longer survival of immunocompromised 
patients, m elanoma could becom e a problem. 
To assess the relationship between immunodeficiency and the 
number of n evi, we studied two patient populations with in1111l1-
nodeficiency caused by comp letely ditrerent mechanisms, i.e., 
HN -positive (HI V + ) patients w ith a virus-induced immunodefi-
ciency and renal transplant recipients (RTR) with a drug-induced 
immunodeficiency. Our rationale was that if both these epidemio-
logic groups had more nevi than controls, they would pro\' ide 
epidemiologic evidence that the excess of nevi was due to immu-
nodeficiency itself rather than to the cause of immunodeficiency. 
MATERIALS AND METHODS 
Cases and Controls This multicenter study was conducted by the 
Reseau d' Epidemiologie en Dermatologie (RED) in six University hospitals 
in France: Brest, Colmar, Limoges, Marseille , Paris, altd Tours. Two 
cross- sectional studies were pcrfonned si.rTIultaneously, one to C0l11pare 
R TR with matched controls (study 1) and the other to compare HlV + 
patients with matched controls (study 2). 
In the RTR study, eligible cases were randomly selected from RTR 
consulting at each transplant center. The onJy selection criteria were 
Caucasian phenotype and transplantation at least 2 y before. Controls were 
recruited ei ther fro m "public health centers" where people from the general 
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Table I. No Significant Difference Between Renal 
Transplant Recipients and Controls with Regard to Age, 
Sex, Weight, and Sun Exposure 
RTR (110)" Controls (110)" 
Age 42.8 :!:: 11.2 42.7 :!:: 11.7 
Sex 68M/42F 68M/42F 
Weight 65.3 :!:: 13.7 68.8 :!:: 13.8 
Sun exposure" 
Vacations 2002 h :!:: 3093 2069 h :!:: 1839 
Vacation at seaside 1662 h :!:: 3061 1604 h :!::1698 
Leisure 1154 h :!:: 3201 1162 h ::': 2251 
Leisure at seaside 520 h :!:: 1240 49 1 h ::': 1645 
Occupational 145 days:!:: 542 345 days :!:: 2450 
Q LUe cumulati ve SUll exposure with un covered back. 
b Mean:!: SO. 
p 
0.8 
0.06 
0.84 
0.86 
0.55 
0.61 
0.41 
population are randomly called for check-ups or from hospital patients. 
Hospital patients admitted for skin disease, trauma (possible relation to 
outdoor activities and sun exposure), and chronic disease were excluded. 
Controls were matched with R.TR. with regard to age (::': 5 y), sex, and hair 
color (red/blond, brown, black). In HIV+ study 2, eligible cases were 
randomly selected from HlV + patients followed at each center. The only 
selection criteria was CD4+ lymphocyte count less than 400. Controls were 
recruited and matched in the same way as in the RTR stndy. 
Nevus counts and interv iews were p erfOr11'1Cd at each center in cases and 
controls by the same dermatologist. These dermatologists were specially 
rrained to apply the sam e counting technique. Any darkly pigmented lesion 
grea ter than 2 111111 in dianlcter \-vas counted as a 1l1elanocyti c nevus if it \vas 
not considered to be any of the following: a freckle (poorly defined lesions , 
light to medium brown. less than 3 mm) , a seborrheic keratosis (lusterl ess 
surface with patterned fine fissure or plugged folli cular orifice), a solar 
lentigo (light brown pigmented lesions with irregular outlines located on 
exposed areas), a pigmcnted basa l cell carcinoma, a pigmented actinic 
keratosis, or a pigmented dermatofi broma. Lcntigo simplex was not ex-
cluded from counting because there are no absolute clinical criteria to 
distinguish it from junctional nevus and because lentigo is probably the 
earlies t step in the ontogeny of nevi. Nevi were classifIed into two size 
categories: less than 5 mm in di ameter (N < 5) and equal to or larger d13n 
5 mID (N ;O: 5). Atypical nevi were defined as N ;0: 5 displaying at least two 
of the following criteria: irregular border , irregular color distribution. and 
asynunetry. Nevi were counted on three arcas: on the left and right 
forearms, representative of regula.rly exposed arcas; on the back, represen-
tative of intermittently exposed areas; and on the buttocks. representati ve of 
ne ver exposed areas. Interviews 'were conducted 'with a standardized 
questionnaire recording successive places ofresidcnce, outdoor activities for 
leisure and vacation , occupational exposure, an d lise of tanning salons. Sun 
exposure was quantified by estimating thc total cUlllulative llumber of hours 
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spcnt outdoors with uncovered back for leisure, vacation. a.nd/ or occupa-
tion. 
Statistical Analysis General characteristics of patients and total cumu-
lative life sun exposure in cases and matched conrrols were compared by 
univariate pajred analysis. Then nunlber of nevi "vas c0111pared by paired 
analysis of variance. When the total number of nevi was significantly 
different (p < 0.05) in patients and controls, the number of small nevi and 
large nevi ~'ere also c0l11pared separately. To take into account the 
potentially confounding factors, cumulative sun exposures expresscd by 
quartiles of the distribution and weight were used in multivariate analysis 
also including age and sex (matching variables) as adjustment variables. As 
the distribution of nevi was not normal , the analyses were performed after 
logaritillnic transfornlutiol1. Paired analysis of variance and unconditional 
logistic regrcssion were performed using BMDP statistical software. Inc. 
(Berkeley, CAl. 
RESULTS 
There Is an Excess of Nevi in Renal Transplant Recipients 
A total of 110 RTR and 110 controls were enrolled in study 1. As 
shown in Table I the two groups were matche d with regard to sun 
exposure and weight although w e ight was slightly lower in the 
RTR group. One hundred and six (96%) had b een treated witl1 
cyclosporin A for 4.5 :':: 1.8 Y (range: 1.3-9) and 100 (91 %) witll 
azathioprin for 3.6 :':: 2.1 Y (range: 0.1-8). One hundred (91 %) 
re quired dialysis for 3 .2 :':: 4 Y (range: 0.1-20). Mean time from 
transplantation was 5.1 :!:: 3 .1 y. Before and after adjustment for 
age, sex, weight, and sun exposure, the number of nevi was hig h er 
in RTR than controls (Table II). TIllS differe nce was significant for 
both N < 5 and N 2: 5 regardless of the site (Table II). There was 
no significant diffe ren ce between RTR and controls with regard to 
the number of atypical nevi whatever the site. It should b e 
m entione d , however, that the number of p atients with at least one 
atypical n evus was sigtllficantly higher in RTR than controls (29 vs 
17, P < 0.05). Attempts to correlate number of nevi with time from 
transplantation or with type or duration of immunosuppressive 
drugs in renal transplant recipients were unsu ccessfi.ll. 
There Is an Excess of Nevi in HIV-Infectcd Patients Eighty 
four HIV + patie nts and 84 controls were enrolled in the HIV + 
study. T he two groups were match ed except w ith regard to weight 
(Table III) . Sixty-.five p atients (77%) had b een treated with 
zidouudine and 28 (33 %) with didanosine. M ean CD4+ lympho-
cyte count in patients was 102.3 :!:: 105.5 . Before and after 
adjustment for age, sex, weight, and stm exposure , the number of 
small n evi (N < 5) was higher in HIV+ patients than controls 
(Table IV). There was no sigtlificant differen ce in the number of 
larger n evi (N 2: 5) although tlllS was probably due to their very 
low number. Number of small n evi was significantly higher in 
Table II. Excess Nevi in Renal Transplant Recipients versus Controls 
RTR (110)" 
On the 3 sites 
Total number 25.4 :!:: 24.2 
n < 5 23.2 ::': 22.8 
n ;0: 5 2.2 :!:: 2.9 
Back 
Total number 16.0 :!:: 17.9 
n < 5 14.5 ::': 16.8 
11 ;0: 5 1.5 :!:: 2.5 
ForCarnlS 
Total number 7.2 :!:: 8.8 
N < 5 6.7 ::': 8.1 
n ;O: 5 0.5 ::': 1. 2 
Buttocks 2.2 :!: 2.9 
<I M e an ::±: SO. 
b After adjustment tor age . sex, weight, sun exposu re. 
Control s (J 1 0) " 
15.3 ± 11.3 
14.1 ::': 10.7 
1.2 :!:: 2.1 
9.2 :!:: 7.7 
8. 1 ::': 7.3 
1.0 :!:: 1.9 
4.8 :!:: 4.9 
4.7 :!:. 4.7 
0.2 :!: 0.5 
1.4 :!:: 1.9 
Difference 
(95'% Confidencc Interval) 
+ 10.1 (5.4-14.7) 
+ 9.1 (4 .8-13.4) 
+l (0.4-1.6) 
+ 6.8 (3 .3-1 0.4) 
+ 6.4 (3.1-9.8) 
+ 0.5 (0.1-1.0) 
+ 2.4 (0.6-4.2) 
+ 2.0 (0.4-3.7) 
+0.3 (0. 1-0.4) 
+ 1.2 (0.2-1.4) 
p 
crude/ adjustment" 
< 0.00110.01 
< 0.001/0.01 
< 0.011< 0.0 1 
< 0.01/< 0.05 
< 0.05 
< 0.05 
< 0.01/< 0.01 
0.01 
0.02 
< 0.05 / 0.05 
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Table III. No Significant Difference between HIV + 
Patients and Controls as Regard to Age, Sex, and Sun 
Exposure, but a Lower Weight in HIV+ Patients 
HIV+ (84)" Controls (84)" p 
Age 36.7 :t 7.9 36.3 :t 8.6 0.8 
Sex 64 M120 F 64 M120 F 
Weight 59.7 :t 9.9 70.2 :t 13.8 < 0.001 
Sun exposure" 
Vacations 2889 h :t 2555 2618 h :t 4226 0.6 
Vacation at seaside 2576 h :t 2568 2352 h :t 4083 0.66 
Leisure 940 h :t 2832 483 h :t 941 0.13 
Leisure at seaside 575h :t 2312 379 h :t 716 0.46 
Occupational 38 days :t 122 54 days :t 196 0.52 
• Mean :: SO. 
I, Life cumulative sun-exposure with uncovered back . 
HIV + patients than in controls, whatever the site. After adjust-
ment, however, this remained significant only on the back (Table 
IV). Patients and controls were not significantly different according 
to the number of atypical nevi whatever the site . The number of 
individuals with at least one atypical nevus was also not diiferent in 
HIV + patients and controls (11 vs 9). There was no significant 
correlation between the total number of nevi and immunodefi-
ciency criteria, i.e., CD4 + lymphocyte count and severity of 
opportunistic infections on one hand, or between total number of 
nevi and treatment with zidouudine or didanosine (drug intake or 
length of treatment), on the other hand. 
DISCUSSION 
These two parallel cross-sectional studies showed that there was 
more melanocytic nevi in both the HIV+ and RTR groups than 
controls, although the excess was more clear-cut in RTR than 
HIV + patients. It is unlikely that other factors influencing the 
number of nevi, such as age, sex, phenotype, and amount or type of 
sun exposure (Green et Ill, 1989; Richard et Ill, 1993), biased these 
results for two reasons. First, patients and controls were matched 
for age, sex, and hair color. Second, nevus counts were significantly 
higher in patients than in controls on differently exposed skin sites, 
even after adjustment for age, sex, weight, and sun exposure. 
Dermatologists who counted nevi knew the status of the patients or 
controls, but this potential bias probably did not play an important 
role because they applied a precise counting teclmique. 
In HIV + patients, the increase in the number of nevi may be 
attributed either to viral infection or immunodeficiency whereas in 
RTR it may be attributed either to renal failure, drugs, or 
immunodeficiency. The concordance of the results in these two 
populations with completely different mechanisms of immunodefi-
ciency, however, suggests that the excess of nevi is due to 
immunodeficiency. Although these results do not rule out a 
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possible direct effect of chemotherapeutic agents in the develop-
ment of nevi, especially of the acral type (Green ct Ill, 1993), they 
provide the first evidence that immunodeficiency itself can promote 
the development of nevi. We were un able to show a correlation 
between the number of nevi and parameters assessing severity of 
immunodeficiency such as CD4+ lymphocyte count and severity of 
opportun.istic infections in HIV + patients, on one hand, and time 
from transplantation or type of immunosuppressive drugs in RTR 
on the other hand. Tllis apparent lack of correlation can be 
explained because all patients were severely immunocompromised 
with a CD4 + lymphocyte count under 400 in HIV + patients 
(mean = 102.3) and a long h.istory of drug-induced immunodefi-
ciency in RTR (mean time from transplantation: 5.1 y). The fact 
that patients with less severe immunodeficiency were not enrolled 
in these studies makes it difficult to demonstrate a proportional 
relationship between number of nevi and degree of immunodefi-
ciency. 
Our results support the hypothesis of immune surveillance of 
nevi. T here is much evidence that nevi are regulated by genetic 
factors, are cOITelated with phenotype markers (Gallagher ei ai, 
1990b; Brogelli et ai, 1991), and are promoted by sun exposure 
(Gallagher et Ill, 1990a; Richard et Ill, 1993). T he immune system 
may also playa important role in the control of nevi. Because all 
melanoma in one group of renal allograft recipients arose from nevi 
(Greene et ai, 1981) whereas fewer than one in five melanomas in 
normal persons do, Ross (1989) suggested that immune surveil-
lance normally prevents melanoma from growing in or near nevi. 
He hypothesized that immune surveillance was able not only to kill 
or hold in check melanoma but was also able to control precursors 
by destroying nevi or limiting their growth. It is tempting to 
specul ate that a defect in immune surveillance could also be 
implicated in the development of an excess of nevi in genetically 
predisposed individuals, as in "atypical mole" syndrome. In tllis 
regard, cases of eruptive dysplastic nevi have been reported in 
HIV + patients (Duvic et Ill, 1989), and transplant recipients (Barker 
and Donald, 1988). We have to underline, however, that although 
more RTR than controls had at least one atypical nevi, there was 
no clear excess of atypical nevi in our patients. 
The mechanisms by which sun exposure (Gallagher et Ill, 1990a; 
Richard et Il l, 1993) promotes the development of nevi are un-
Imowl1 (pallowski et Il l , 1991). Ultraviolet-induced DNA danlage 
might be involved (Miller, 1985) but may not be the only expla-
nation. It has been widely demonstrated that exposure to ultraviolet 
light affects the ability to eliminate infectious pathogens, reject skin 
cancer, and mount both delayed-type hypersensitivity and contact 
hypersensitivity reactions (Krutmann and Elmets, 1988; Roberts et 
ai, 1989, Goettsch et ai, 1993). Our epidemiologic data raise the 
possibility that ultraviolet-induced immune suppression could be 
one of the mechanisms by wllich sun exposure callSes an increase in 
the number of nevi . 
Immunocompromised patients are at higher risk for skin tumors. 
In trus regard skin carcinoma is more frequent in transplanted 
Table IV. Excess of Nevi in HIV+ Patients versus Controls 
HIV (84)" 
On the 3 sites 
Total number 21.5 :t 20.4 
n < 5 20.6 :t 18.2 
n 2!: 5 0.8 :t 1.4 
Back 
Total number 14.9 :t 14.5 
n < 5 14.2 ::': 14.2 
n 2!: 5 0.7 :t 1.4 
Forearms 5.1 :t 5.9 
Buttocks 1.5 :t 2.6 
(I Mean :t SD . 
/. After adjustment for age. sex , weight, sun exposure. 
Controls (84)" 
13.1 ::': 13.1 
12.3 ::':: 12.5 
0.8:t 1.4 
8.6 :t 9.6 
8.0 :t 9.1 
0.7:t 1.3 
3.8 ::':: 4.1 
0.7 :t 1.0 
Difference 
(95% Confidence Interval) 
+ 8.4 (3.7-13.1) 
+8.3 (3.7-12.9) 
0(-0.4 -0.5) 
+ 5.7 (2 .9-9.7) 
+ 6.2 (5.3-9 .1) 
0(- 0.3- 0.4) 
+ 1.3 (-0.11-2.8) 
+ 0.6 (0.3-1.4) 
p 
Crude/ Adjustmentb 
< 0.0011< 0.001 
< 0.0011 < 0.001 
0.48/0.70 
< 0.0011 < 0.001 
< 0.01 
0.4 
0.03/0.4 
< 0.01/< 0.3 
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patients, and Kaposi's sarcoma is more frequent in both tr3l1S-
planted patients and HIV + patients ( Walz ef ai, 1992; Sheil e/ ai, 
1993). The fact that we also observed an excess of melanocytic 
nevi, which are the most important risk factors of melanoma (Grob 
et ai, 1990) and its only known precursor, suggests that imJ11uno-
compromised patients may also be at higher ri sk for melanoma. 
Melanoma has already been reported in graft recipients (Vilardell ef 
ai, 1992), in HIV + patients (Tindall et ai, 1989), and after Hodgkin 
disease (Tucker ef ai, 1(85). An excess of melanoma has even been 
described in transplant recipients (Birkeland et a/, 1975). Ln a recent 
collaborative European study from several transplant centers , how-
ever, the incidence of melanoma in 25,914 fema les was only 16 as 
cOlTlpared to all expected incidence of 12 (Stewart e/ a/, 1995) . 
Because the inciden ce and the delay of occurence of cancers in 
i.ITl.lTlunocompromised patients varies according to the type of 
tumor and may depend on age of onset and length of immune 
suppression, the excess of nevi o bserved in both transplanted and 
HIV + patients suggests that further studies are warranted to 
evaluate the long-term risk of melanoma. 
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